Thursday, October 28, 2021

In Play

These stocks could be In Play. Add them to your watch list.

Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave Substance over Cyber Bullying

STAT Reporter Triples Down on CytoDyn (OTCQB: CYDY) Rhetoric with Failed Cyber Bullying...

Miami, FL – May 8, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Misleading Headline on CydoDyn (CYDY) Triggers Algo Selling

Top short seller Andrew Left from Citron Research facilitated a bear raid led by Tim Sykes and his army of smaller short sellers, and eventually Adam Feuerstein chimed...

CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street

It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is something very...

STAT News’ Adam Feuerstein Uses Up His Nine Lives on CytoDyn (OTCQB: CYDY)

The feline has attacked CytoDyn Inc. (OTCMKTS: CYDY) nine times within the last 8 months in an attempt to discredit the company as CYDY...

CytoDyn (OTCQB: CYDY) Stuns FDA with 400% Improvement in 14 Day Mortality

CytoDyn Inc. (OTCMKTS: CYDY) just released stunning numbers which takes the company down one of two roads.  The first road is a quick review by the FDA...

BuyersStrike Short Attack Ahead of NASDAQ Uplisting

This morning shares of CytoDyn Inc. (OTMKTS: CYDY) screamed higher in very active trading and touched $7.00 per share to a $4.14 billion market...

Mesoblast Crashed on Poor DSMB Report Leaving CytoDyn as Sole Survivor in COVID-19 Therapeutics

Only Mesoblast (NASDAQ:MESO) and CytoDyn Inc. (OTCMKS: CYDY) had mortality as a primary endpoint in severe to critical COVID-19.

The Great CytoDyn (OTCQB: CYDY) Bear Raid Fails to Impress

Miami, FL – February 10, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Adam Feuerstein’s Fishing Expedition on CytoDyn (CYDY) Continues to Cast an Empty Net

Instead of reporting on the great advancements that CytoDyn Inc. (OTCMKTS: CYDY) has just announced the completion of  enrollment in its first randomized clinical trial for...
Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave Substance over Cyber Bullying

Galectin Therapeutics, Inc. (NASDAQ: GALT) Most Feared Biotech Analyst Losing Relevance as Investor’s Crave...

Miami, FL - September 21, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

Latest News